We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Endovascular Stroke Treatment Outcomes After Patient Selection Based on Magnetic Resonance Imaging and Clinical Criteria

Thabele M. Leslie-Mazwi, MD1; Joshua A. Hirsch, MD1; Guido J. Falcone, MD, MPH2; Pamela W. Schaefer, MD3; Michael H. Lev, MD3; James D. Rabinov, MD1; Natalia S. Rost, MD, MPH2; Lee Schwamm, MD2; R. Gilberto González, MD3
[+] Author Affiliations
1Neuroendovascular Program, Massachusetts General Hospital, Boston
2Stroke Service, Massachusetts General Hospital, Boston
3Neuroradiology Division, Massachusetts General Hospital, Boston
JAMA Neurol. 2016;73(1):43-49. doi:10.1001/jamaneurol.2015.3000.
Text Size: A A A
Published online

Importance  Which imaging modality is optimal to select patients for endovascular stroke treatment remains unclear.

Objective  To evaluate the effectiveness of specific magnetic resonance imaging (MRI) and clinical criteria in the selection of patients with acute ischemic stroke for thrombectomy.

Design, Setting, and Participants  In this observational, single-center, prospective cohort study, we studied 72 patients with middle cerebral artery or terminal internal carotid artery occlusion using computed tomographic angiography, followed by core infarct volume determination by diffusion weighted MRI, who underwent thrombectomy after meeting institutional criteria from January 1, 2012, through December 31, 2014. In this period, 31 patients with similar ischemic strokes underwent endovascular treatment without MRI and are categorized as computed tomography only and considered in a secondary analysis.

Interventions  Patients were prospectively classified as likely to benefit (LTB) or uncertain to benefit (UTB) using diffusion-weighted imaging lesion volume and clinical criteria (age, National Institutes of Health Stroke Scale score, time from onset, baseline modified Rankin Scale [mRS] score, life expectancy).

Main Outcomes and Measures  The 90-day mRS score, with favorable defined as a 90-day mRS score of 2 or less.

Results  Forty patients were prospectively classified as LTB and 32 as UTB. Reperfusion (71 of 103 patients) and prospective categorization as LTB (40 of 103 patients) were associated with favorable outcomes (P < .001 and P < .005, respectively). Successful reperfusion positively affected the distribution of mRS scores of the LTB cohort (P < .001). Reperfusion was achieved in 27 LTB patients (67.5%) and 24 UTB patients (75.0%) (P = .86). Favorable outcomes were obtained in 21 (52.5%) and 8 (25.0%) of LTB and UTB patients who were treated, respectively (P = .02). Favorable outcomes were observed in 20 of the 27 LTB patients (74.1%) who had successful reperfusion compared with 8 of the 24 UTB patients (33.3%) who had successful reperfusion (P = .004). The ratio of treated to screened patients was 1:3.

Conclusions and Relevance  Prospective classification as LTB by MRI and clinical criteria is associated with likelihood of favorable outcome after thrombectomy, particularly if reperfusion is successful. Selection of patients using MRI compares favorably with selection using computed tomographic techniques with the distinction that a higher proportion of screened patients were treated.

Figures in this Article


Place holder to copy figure label and caption
Modified Rankin Scale (mRS) Scores at 90 Days in the Likely to Benefit (LTB) Cohort

Distribution of scores at 90 days in the LTB cohort comparing those with successful and failed reperfusion. The dashed lines distinguish between favorable and unfavorable outcomes. A significant difference was found between the successful and failed reperfusion groups in the overall distribution of scores (P < .001; Cochran-Mantel-Haenszel test).

Graphic Jump Location





You need to register in order to view this quiz.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Does This Patient With Headaches Have a Migraine or Need Neuroimaging?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient With Headache Have a Migraine or Need Neuroimaging?